Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Phase 2a, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Multiple Doses of Orally Administered EDP-938 Against Respiratory Syncytial Virus Infection in the Virus Challenge Model.
Brief Summary: A randomised, Phase 2a, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics and antiviral activity of multiple doses of orally administered EDP-938 in healthy subjects infected with RSV-A Memphis 37b. This study is designed to compare the antiviral effect of EDP-938 compared to a placebo control in the respiratory syncytial virus challenge model.


Options:
A: Arm Label: SynGEM low dose; Type: EXPERIMENTAL; Interventions: Biological: SynGEM | Arm Label: SynGEM high dose; Type: EXPERIMENTAL; Interventions: Biological: SynGEM | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: BIOLOGICAL; Name: SynGEM; Assigned to Arm(s): SynGEM high dose, SynGEM low dose | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): placebo
B: Arm Label: RSV vaccine formulation 1 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003895A (formulation 1) | Arm Label: RSV vaccine formulation 2 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003898A (formulation 2) | Arm Label: RSV vaccine formulation 3 Group; Type: EXPERIMENTAL; Interventions: Biological: RSV vaccine GSK3003899A (formulation 3) | Arm Label: Boostrix Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Boostrix | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003895A (formulation 1); Assigned to Arm(s): RSV vaccine formulation 1 Group | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003898A (formulation 2); Assigned to Arm(s): RSV vaccine formulation 2 Group | Intervention Type: BIOLOGICAL; Name: RSV vaccine GSK3003899A (formulation 3); Assigned to Arm(s): RSV vaccine formulation 3 Group | Intervention Type: BIOLOGICAL; Name: Boostrix; Assigned to Arm(s): Boostrix Group
C: Arm Label: EDP-938 Arm A; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 1 | Arm Label: EDP-938 Arm B; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 2 | Arm Label: Placebo Arm C; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: EDP-938 Arm D; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 3 | Arm Label: EDP-938 Arm E; Type: EXPERIMENTAL; Interventions: Drug: EDP-938 Dose 4 | Arm Label: Placebo Arm F; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: EDP-938 Dose 1; Assigned to Arm(s): EDP-938 Arm A | Intervention Type: DRUG; Name: EDP-938 Dose 2; Assigned to Arm(s): EDP-938 Arm B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Arm C | Intervention Type: DRUG; Name: EDP-938 Dose 3; Assigned to Arm(s): EDP-938 Arm D | Intervention Type: DRUG; Name: EDP-938 Dose 4; Assigned to Arm(s): EDP-938 Arm E | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Arm F
D: Arm Label: 1; Type: OTHER; Interventions: Other: Control | Arm Label: 2; Type: OTHER; Interventions: Device: Masks | Arm Label: 3; Type: OTHER; Interventions: Device: Masks & hand hygiene | Intervention Type: DEVICE; Name: Masks; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Masks & hand hygiene; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): 1

Answer: C